Trumbo, Henry http://orcid.org/0000-0001-6793-9643
Kaluza, Karolina
Numan, Syed
Goodnough, Lawrence T.
Funding for this research was provided by:
American Regent
Article History
Accepted: 15 February 2021
First Online: 9 April 2021
Declarations
:
: This study was supported by American Regent, USA, which holds the marketing rights for ferric carboxymaltose in the USA, and which provided funding to Advera Health Analytics, Inc. (Santa Rosa, California, USA) to conduct the FAERS data extraction and analysis.
: Henry Trumbo is a consultant for American Regent, Daiichi Sankyo, and Allergan. Lawrence T. Goodnough is a consultant for American Regent. Karolina Kaluza and Syed Numan are employees of American Regent, the manufacturers of ferric carboxymaltose.
: Not applicable.
: Not applicable.
: Not applicable.
: The source data and analytics for this study were provided by Evidex®, licensed by Advera Health Analytics, Inc., and are not publicly available. Healthcare Cost and Utilization Project (HCUP) data are made publicly available by the Agency for Healthcare Research and Quality (AHRQ).
: Code used to conduct this analysis was provided by Evidex<sup>®</sup> (which is not publicly available), PostgreSQL (a free and open-source relational database), and Microsoft<sup>®</sup> Excel<sup>®</sup>.
: Henry Trumbo and Lawrence T. Goodnough contributed to the interpretation of data and to reviewing and writing of the original report. Karolina Kaluza and Syed Numan contributed to the conception and design of the analysis, the interpretation of data, and reviewing and writing of the original report. All authors contributed to the writing of this letter and read and approved the final version.